Bavarian Nordic Issues New Shares In Connection With Exercise Of Warrants

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

KVISTGAARD, Denmark, May 27, 2014 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Company's share capital has been increased by nominally DKK 185,020 as a consequence of the exercise of warrants. After registration of the capital increase, Bavarian Nordic A/S' share capital amounts to DKK 261,128,630.

Help employers find you! Check out all the jobs and post your resume.

Back to news